» Authors » P E Brenchley

P E Brenchley

Explore the profile of P E Brenchley including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 1005
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fresquet M, Rhoden S, Jowitt T, McKenzie E, Roberts I, Lennon R, et al.
J Autoimmun . 2019 Aug; 106:102308. PMID: 31395435
Patients with membranous nephropathy have autoantibodies against PLA2R (up to 80%), or THSD7A (up to 2%). We previously described the immunodominant epitope within PLA2R but epitopes in THSD7A are still...
2.
Simler N, Brenchley P, Horrocks A, Greaves S, Hasleton P, Egan J
Thorax . 2004 Jun; 59(7):581-5. PMID: 15223865
Background: Angiogenesis has been implicated in the pathogenesis of idiopathic interstitial pneumonia (IIP). The aim of this study was to examine the relationship between plasma concentrations of the angiogenic cytokines...
3.
Brenchley P
Ann Rheum Dis . 2002 Mar; 60 Suppl 3:iii71-4. PMID: 11890660
No abstract available.
4.
Chaudhry I, ODonovan D, Brenchley P, Reid H, Roberts I
Histopathology . 2001 Oct; 39(4):409-15. PMID: 11683943
Aims: Tumour vascularity and vascular endothelial growth factor (VEGF) expression were studied in 41 primary brain tumours of astrocytic and oligodendroglial origin, in order to define the potential role of...
5.
Allen A, Bailey E, Brenchley P, Buck K, Barratt J, Feehally J
Kidney Int . 2001 Sep; 60(3):969-73. PMID: 11532091
Background: In IgA nephropathy (IgAN), circulating IgA1 molecules display an abnormal pattern of O-glycosylation. This abnormality may potentially contribute to mesangial IgA1 deposition, but this is unproven because the O-glycosylation...
6.
Brenchley P, Williams S, Coupes B, Short C
Transplantation . 2001 Jun; 71(9):1355-6. PMID: 11397979
No abstract available.
7.
Coupes B, Williams S, Roberts I, Short C, Brenchley P
Nephrol Dial Transplant . 2001 Feb; 16(2):361-7. PMID: 11158413
Background: Evidence from animal models supports the hypothesis that dysregulated transforming growth factor beta(1) (TGF beta(1)) expression plays a role in chronic allograft rejection, the progression of diabetic nephropathy and...
8.
Roberts I, Brenchley P
J Clin Pathol . 2000 Dec; 53(11):858-62. PMID: 11127270
Background/aims: Mast cells, when activated, secrete a large number of fibrogenic factors and have been implicated in the development of fibrotic conditions of the liver, lung, and skin. There is...
9.
Brenchley P
Clin Exp Immunol . 2000 Sep; 121(3):426-9. PMID: 10971506
No abstract available.
10.
Watson C, WEBB N, Bottomley M, Brenchley P
Cytokine . 2000 Aug; 12(8):1232-5. PMID: 10930302
Dysregulated vascular endothelial growth factor (VEGF) expression has been implicated as a major contributor to the development of a number of common disease pathologies. The aim of this study was...